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Abstract
Mechanical signal transduction in bone tissue begins with load-induced activation of several 
cellular pathways in the osteocyte population. A key pathway that participates in 
mechanotransduction is Wnt/Lrp5 signaling. A putative downstream mediator of activated Lrp5 is 
the nucleocytoplasmic shuttling protein β-catenin (βcat), which migrates to the nucleus where it 
functions as a transcriptional co-activator. We investigated whether osteocytic βcat participates in 
Wnt/Lrp5-mediated mechanotransduction by conducting ulnar loading experiments in mice with 
or without chemically induced βcat deletion in osteocytes. Mice harboring βcat floxed loss-of-
function alleles (βcatf/f) were bred to the inducible osteocyte Cre transgenic 10kbDmp1-CreERt2. 
Adult male mice were induced to recombine the βcat alleles using tamoxifen, and intermittent 
ulnar loading sessions were applied over the following week. Although adult-onset deletion of βcat 
from Dmp1-expressing cells reduced skeletal mass, the bone tissue was responsive to mechanical 
stimulation as indicated by increased relative periosteal bone formation rates in recombined mice. 
However, load-induced improvements in cross sectional geometric properties were compromised 
in recombined mice. The collective results indicate that the osteoanabolic response to loading can 
occur on the periosteal surface when β-cat levels are significantly reduced in Dmp1-expressing 
cells, suggesting that either (i) only low levels of β-cat are required for mechanically induced bone 
formation on the periosteal surface, or (ii) other additional downstream mediators of Lrp5 might 
participate in transducing load-induced Wnt signaling.
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INTRODUCTION
Among the environmental factors that influence skeletal size and strength, mechanical 
loading is critical [1, 2]. Loss of adequate mechanical stimulation to bone tissue, as occurs in 
long-term bedrest, muscular paralysis, immobilization, and reduced gravitational 
environments, results in reduced bone mass and strength due to increased bone resorption 
and suppressed bone formation [3]. Conversely, enhanced mechanical stimulation to the 
skeleton has bone-building and/or anti-resorptive effects [4, 5]. Although the identity of the 
bone cell “mechanoreceptor” molecule(s)—which serves to monitor the mechanical 
environment surrounding the cell and generate a biochemical cascade inside the cell—is 
currently unresolved, it is becoming clear that the osteocyte is the cell type that receives and 
transduces mechanical information in bone [6, 7].
The molecular biology of osteocyte mechanotransduction is an unresolved field, but several 
key signaling pathways have been identified that have withstood the tests of time and 
experimental reproducibility. Among them is the Wnt pathway, which mediates many 
developmental and regulatory processes in numerous tissues [8, 9]. The importance of Wnt 
signaling in bone metabolism has been demonstrated in many clinical contexts; for example, 
the high-bone-mass (HBM) phenotypes in patients with activating mutations in the Wnt co-
receptors Lrp5 [10] and Lrp4 [11], the HBM phenotypes in patients with inactivating 
mutations in the Lrp5/6 inhibitor Sost [12], and the low bone mass phenotypes in patients 
with inactivating mutations in Lrp5 [13] and Lrp6 [14].
Beyond its role in general bone metabolism, the Wnt pathway is intimately involved in bone 
cell mechanotransduction. Mechanical stimulation of cultured bone cells activates 
components of the canonical Wnt signaling cascade [15–18]. Moreover, genetic deletion of 
the Wnt co-receptor Lrp5, or overexpression of the Lrp5 inhibitor Sost, abolishes load-
induced bone formation [19–22]. Conversely, activating mutations in Lrp5 enhance load-
induced bone gain [21, 23]. While ample experimental evidence has defined Lrp5’s role in 
mechanotransduction, the downstream mediators of mechanically activated Lrp5 are less 
well studied. Lrp5 is commonly thought to signal through the canonical Wnt pathway, which 
relies on the nucleocytoplasmic shuttling protein β-catenin (βcat) to promote Wnt-induced 
gene transcription [24, 25].
Although the skeletal phenotype of mice with βcat-deficient osteoblasts/osteocytes is 
superficially similar to that of mice with Lrp5-deficient osteoblasts/osteocytes (low bone 
mass phenotype), the cellular mechanisms driving their phenotypes are distinct. βcat-
deficient mice exhibit low bone mass because of increased bone resorption with little to no 
changes in bone formation [26, 27], whereas Lrp5-deficient mice exhibit low bone mass 
because of reduced bone formation with little to no changes in bone resorption [20, 28]. 
Given that (1) mechanical loading stimulates bone formation through Lrp5, that (2) βcat is a 
key downstream signaling relay in the canonical Wnt/Lrp5 pathway, but (3) βcat plays a 
Kang et al. Page 2
Bone. Author manuscript; available in PMC 2017 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
prominent role in controlling bone resorption but not formation, it seems plausible that βcat 
might not be required for load-induced bone formation.
To assess the role of βcat in load-induced bone formation, we conducted in vivo mechanical 
loading studies using mice that harbored floxed loss-of-function βcat alleles (βcatf/f) and a 
transgene for inducible Cre expression in osteocytes and late-stage osteoblasts (10kbDmp1-
CreERt2) [29]. This approach permitted us to raise up phenotypically normal mice to 
adulthood, then induce deletion of βcat (via tamoxifen injection) from bone cells and 
immediately begin mechanical loading experiments. Our results indicate that although adult 
onset deletion of βcat from Dmp1-expressing cells reduced bone mass and density, 
osteocyte-selective inactivation of βcat did not prevent load-induced bone formation. 
However, geometric adaptation to loading was impaired. These findings indicate that the 
osteogenic response to loading can occur even with a deficiency of osteocytic β-cat, 
suggesting that other downstream mediators of Lrp5 might participate in transducing load-
induced Wnt signaling.
MATERIALS AND METHODS
Experimental Mice
All mice were homozygous for a floxed loss-of-function βcat (βcatf/f) allele that has been 
described previously [30]. Briefly, these mice harbor loxP sites in introns 1 and 6 of the βcat 
(Ctnnb1) gene. 10kbDmp1-CreERt2 transgenic mice have been described previously [29]. 
These mice harbor a cDNA for the Cre recombinase–mutant estrogen receptor fusion protein 
that results in Cre sequestration in the cytosol (away from the chromatin) until the selective 
ligand tamoxifen is encountered [31]. The CreERt2 gene was driven by a 10kb fragment of 
the Dentin Matrix Protein-1 (Dmp1) promoter, which provides osteocyte and late osteoblast 
selectivity of expression [32]. βcatf/f mice were maintained on a C57BL/6 background 
and 10kbDmp1-CreERt2 mice were maintained on a mixed 129/C57BL6 background. βcatf/f 
mice were bred to 10kbDmp1-CreERt2 over several generations to generate littermate βcatf/f 
mice that were either hemizygous (CreERt2+) for the 10kbDmp1-CreERt2 transgene or 
nontransgenic (CreERt2−) for the 10kbDmp1-CreERt2 transgene. Male mice were selected 
for the experiments. Offspring were same sex–housed in cages of three to five (independent 
of Cre genotype) and given standard mouse chow [Harlan Teklad 2018SX; 1% Ca; 0.65% P; 
vitamin D3 (2.1 IU/g)] and water ad libitum. All animal procedures were performed in 
accordance with relevant federal guidelines and conformed to the Guide for the Care and use 
of Laboratory Animals (8th Edition). The animal facility at Indiana University is an 
AAALAC-accredited facility.
Cre induction
To induce adult-onset recombination of the floxed βcat alleles, mice were treated with 20 
mg/kg tamoxifen free base (M&P Biomedicals, Santa Ana, CA). Tamoxifen powder was 
dissolved in dimethyl formamide (DMF) at a concentration of 100mg/mL and then 
suspended in ~150 μL of corn oil for IP injection. Mice that received vehicle treatment (no 
Cre induction) were injected with an equivalent volume of DMF alone suspended in 150 μL 
of corn oil. Mice were treated with single injections of tamoxifen or vehicle 6 days prior and 
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3 days prior to the first day of loading, and again 3 days and 9 days after the first day of 
loading (4 total injections over the experiment). Details for the experimental schedule are 
shown in the Fig 1A. Visual monitoring of tissue specificity for Cre induction was 
qualitatively assessed by examining tissue sections from tamoxifen-treated Dmp1-CreErt2 
transgenic mice that co-expressed the tdTomato (Ai9) Cre-reporter allele, which harbor a 
ubiquitously expressed flox-stop-flox-tdTomato cassette described elsewhere [32].
In vivo ulnar loading and fluorochrome labeling
Mice were loaded based on the ulna loading protocol originally described by Torrance et al 
[33]. At 18 weeks of age, 16 male mice of each Cre genotype began the ulnar loading 
regimen. A haversine waveform was used to apply load to the forelimb using a customized 
electromagnetic actuator at peak force of 2.85 N, 2 Hz, for 180 cycles/day. Before the in 
vivo loading sessions began, five additional mice from each group were sacrificed and the 
right forearm was fitted with a single element strain gauge (EA-06–015DJ-120; 
Measurements Group, Raleigh, NC, USA). The output from the strain gauge was measured 
on a digital oscilloscope as described previously [34]. For in vivo loading, each mouse was 
loaded once per day, every other day for a total of 3 loading days, beginning 3 days after the 
second tamoxifen injection. Calcein (12 mg/kg IP) and alizarin complexone (20 mg/kg IP) 
were injected 3 and 10 days, respectively, after the last loading bout. Mice were sacrificed 10 
days after the alizarin injection. At sacrifice, the left (unloaded) and right (loaded) ulnae 
were dissected, cleaned and fixed in 10% NBF for 2 days followed by storage in 70% 
ethanol at 4°C.
Quantitative histomorphometry and geometric properties
The fixed ulnas were dehydrated in graded ethanols, cleared in xylene, and embedded in 
methylmethacrylate. Thick sections were collected at 1 to 1.5 mm distal to the midshaft 
(hereafter referred to as the “midshaft” location) using a diamond-embedded wafering saw. 
A second set of sections was collected 3 distal to midshaft (hereafter referred to as the 
“distal” location). Sections were ground and polished to ~30 μm, mounted and coverslipped, 
then digitally imaged on a fluorescent microscope. Periosteal and endocortical bone 
formation parameters were calculated at the midshaft and distal locations by measuring the 
extent of unlabeled perimeter (nL.Pm), single-labeled perimeter (sL.Pm), double-labeled 
perimeter (dL.Pm), and the area between the double labeling with Image-Pro software 
(MediaCybernetics Inc., Gaithersburg, MD). The derived histomorphometric parameters 
mineralizing surface (MS/BS), mineral apposition rate (MAR), and bone formation rate 
(BFR/BS) were calculated using standard procedures described elsewhere [35]. Relative 
load-induced bone formation parameters were calculated by subtracting the control arm 
value from the loaded arm value for each mouse.
Additionally, second moment of inertia (mm4) was obtained from the digitized fluorescent 
midshaft ulnar images using the Moment macro in ImageJ software (NIH, Bethesda, MD). 
Each right (loaded) ulnar cross section used for fluorochrome histomorphometry was 
imported into ImageJ, in which the minimum second moments of area (IMIN; mm4) were 
calculated. The same parameters were calculated on the same sections a second time, but 
instead of using the bone surfaces as the section edge, the first label (which reveals the 
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relative position of the bone surface at the start of the experiment) was used to define the 
section. In regions of the periosteal perimeter where no labeling was detected, the final bone 
surface was used as the section edge. This allowed us to compare the initial bone area and 
geometry at the start of the experiment with the area and geometry at sacrifice in the same 
section, after the mechanical loading treatment had incurred its effects.
Dual-energy x-ray absorptiometry (DEXA)
Whole body DEXA scans were collected on isoflurane-anesthetized mice using a PIXImus 
II (GE Lunar) densitometer. All mice were scanned at 21 weeks of age, 2 days prior to 
sacrifice. From the whole body scans, areal bone mineral density (aBMD) and bone mineral 
content (BMC) were calculated for the entire postcranial skeleton and regionally for the 
lumbar spine (L3–L5, inclusive) and hindlimb (all skeletal tissue distal to the acetabulum) 
using the ROI tools. The spine and hindlimb subregion measurements served as a control to 
provide an indication of the effects of tamoxifen and of βcat deletion on general skeletal 
properties.
Laser capture microdissection and quantitative polymerase chain reaction (qPCR)
To assess whether βcat was selectively deleted in bone tissue and not in off-target tissues, we 
evaluated Dmp1 expression in both bone and muscle (positive control). Both CreERt2+ and 
CreERt2− mice were treated with either tamoxifen or oil as described above. Three days 
later, the mice were sacrificed and the right femur, including surrounding muscles, was 
removed, embedded in OCT, and immediately frozen by submersion in dry-ice-cooled 
isopentane. The blocks were mounted on the chuck of a cryostat, and 8 μm-thick sections 
were removed using a previously described tape-transfer system [36]. The sections were 
quickly dehydrated in 100% ethanol, air dried, and mounted to a custom slide compatible 
with a Leica LMD6500 laser capture microscope. Regions of cortical bone and skeletal 
muscle were individually collected into 0.5 ml caps using a 10X lens. Laser capture took 
less than 20 min per sample. RNAs were isolated using NucleoSpin RNA XS (Macherey-
Nagel, Duren, Germany) following the manufacturer’s instructions. Individual RNAs of each 
sample were used to make cDNAs using High Capacity cDNA Reverse Transcription Kits 
(Applied Biosystems) and these cDNAs were subjected to real-time PCR (Applied 
Biosystems 7900HT real-time PCR system). βcat (Ctnnb1) expression was quantitated using 
the 2−ΔCt method and normalized to transcripts for the housekeeper GAPDH.
Statistical methods
Statistical analyses were computed using ANOVA, with Cre genotype (CreERt2+ or 
CreERt2−) and induction (tamoxifen or DMF) as main effects. Significance was taken at P < 
0.05. Two-tailed distributions were used for all analyses and those data are presented as 
means ±SEM.
RESULTS
The induced Dmp1-CreERt2 transgene acts on floxed βcat alleles in bone but not muscle
To determine whether the mouse model we generated could reliably delete βcat in 
osteocytes, and simultaneously avoid recombination in other tissues, we treated CreERt2+ 
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and CreERt2− mice with tamoxifen or oil, sacrificed them 3 days later, then measured βcat 
expression in isolated cortical bone tissue (target tissue) and skeletal muscle (control tissue) 
collected using laser capture microdissection (Fig 1C–D). Control experiments conducted in 
CreERt2− mice revealed that tamoxifen alone (i.e., no Cre present to recombine floxed βcat 
alleles) reduced βcat expression in bone by 33% (Fig. 1C). Among CreERt2+ mice, 
tamoxifen reduced βcat in bone by 65% compared to oil-treated CreERt2+ mice, and by 
72% compared to tamoxifen-treated CreERt2− mice. A similar effect of tamoxifen alone in 
CreERt2− mice was found in skeletal muscle samples (Fig 1D), but tamoxifen did not 
reduce muscle-specific βcat expression in CreERt2+ mice. tdTomato Cre-reporter mice 
revealed tamoxifen-induced recombination in osteocytes and some surface cells, but not in 
muscle (Fig. S1).
Adult onset deletion of βcat from Dmp1-expressing cells reduces skeletal mass and 
density
As an additional control experiment, we probed for changes in spine, lower limb, and total 
body bone mineral density and content among CreERt2+ and CreERt2− mice treated with 
tamoxifen or oil. This analysis was undertaken to confirm that we were successfully deleting 
βcat from the skeleton of adult mice, as βcat deletion from bone previously has been shown 
to reduce skeletal mass and density [37]. In CreERt2− mice, tamoxifen had no significant 
effect on BMC or BMD compared to oil treatment, in any of the skeletal regions analyzed 
(whole body, spine, hindlimb; Fig 2). In CreERt2+ mice, tamoxifen treatment significantly 
reduced whole body and spinal BMD and BMC compared to oil treatment, but the 
tamoxifen-induced reduction observed for the hindlimb did not reach significance.
Deletion of βcat from Dmp1-expressing cells does not prevent load-induced periosteal 
bone formation, but endocortical bone formation and geometric adaptation are impaired
To determine whether βcat in osteocytes/late-stage osteoblasts is required for load-induced 
bone formation, we applied mechanical stimulation to the ulnae of CreERt2− and CreERt2+ 
mice treated with tamoxifen or oil before and during a 1-wk loading regimen. Before 
looking at load-induced bone formation, we first evaluated the effects of tamoxifen alone 
and βcat deletion on histomorphometric measurements in the control ulnae. In the nonloaded 
limbs of CreERt2− mice, tamoxifen treatment resulted in a significant increase in periosteal 
MAR and BFR/BS (Fig. 3A–C; Fig. S2), indicating mildly anabolic properties of tamoxifen 
alone that others have reported [38, 39]. Conversely, in the nonloaded limbs of CreERt2+ 
mice, tamoxifen treatment resulted in a significant decrease in periosteal MS/BS and 
BFR/BS, likely the result of βcat deletion. No differences in mechanical strain were detected 
among groups from the ex vivo strain gauging tests (ẋ = 2740–2980 με ± 58–95με; ANOVA 
p=0.64). All four groups exhibited significant increases in periosteal MS/BS, MAR, and 
BFR/BS, in the loaded ulna compared to the nonloaded ulna (Fig. 3A–C). To compare the 
degree of load-induced bone formation parameters achieved among the different treatment/
genotype groups, we normalized load-induced bone formation values (right ulna) to control 
limb bone formation values (left ulna) using a relative (right minus left) calculation approach 
(Fig. 3D–F). No deficiencies in relative MS/BS, MAR, or BFR/BS were found among the 
mice with βcat deletion, suggesting that anabolic mechanotransduction proceeded normally 
despite a significant reduction in osteocytic/late-osteoblastic βcat. On the endocortical 
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surface, tamoxifen stimulated a significant increase in BFR/BS in the nonloaded limb, 
regardless of Cre status (Fig S3). Load-induced endocortical bone formation rates were 
increased among oil-treated mice but not among tamoxifen-treated mice, regardless of Cre 
status (Fig. S3).
In order to assess changes in ulnar adaptation to loading via alterations in cross sectional 
geometric properties, we calculated the second moment of area along the minor axis (IMIN) 
of each digitized histological before loading (preloading; indicated by the calcein label) and 
after loading (postloading; indicated by the bone edge). Loading significantly increased IMIN 
in all four groups (Fig. 4), to a similar degree reported in previous experiments [34]. 
However, the ratio of postload to preload IMIN was significantly lower in the tamoxifen-
treated CreERt2+ group (βcat deletion) compared to the remaining three groups. Areal 
properties (Tt.Ar and B.Ar) flowed similar trends to those reported for geometric properties 
(Table S1). Those data suggest that while bone formation proceeded relatively normally in 
loaded mice that lacked βcat, the geometric and areal adaptation was not as robust as was 
observed in the βcat replete mice.
DISCUSSION
Our primary objective in this study was to understand whether osteocytic βcat regulates the 
osteogenic response to mechanical loading. Our results indicate that while βcat deletion 
from osteocytes reduced resting (nonloaded limb) bone formation, mechanical loading 
significantly increased periosteal bone formation despite a 65% reduction in βcat expression. 
For these experiments, we chose to use an inducible Cre model (10kbDmp1-CreERt2) to 
recombine the floxed βcat alleles (βcatf/f) in adult mice for two reasons. First, βcatf/f mice 
that harbor the non-inducible 10kbDmp1-Cre transgene do not survive beyond 8–12 wks 
[37]. In vivo mechanotransduction studies are most informative when conducted after the 
growth phase is completed (17 wks of age), so our mouse model approach had the advantage 
of permitting experiments in skeletally mature animals. Second, we were able to conduct the 
loading experiments on mice that had a phenotypically normal skeleton. When mutations 
exert their effects on the skeleton from conception onward, the size, shape, structure, and 
material properties at skeletal maturity can be very different from wild type, non-mutant 
mice due to a lifelong accumulation of effects caused by the mutation. We were able to 
induce βcat deletion and immediately begin loading the ulna. This approach more accurately 
models a scenario of compromised cellular signaling, rather than a cumulative effect on 
tissue properties.
Although load-induced increase in relative (i.e., normalized to the nonloaded left arm) 
periosteal bone formation in mice with βcat deletion was statistically similar to the control 
groups, the absolute increase (i.e., not normalized to the nonloaded left arm) in periosteal 
BFR/BS in the loaded arm was reduced in induced mice. This outcome had the effect of 
generating a significant reduction in the load-induced change in the minimum second 
moment of area (IMIN) among induced mice compared to the control groups, as the change 
from baseline in the loaded arm (rather than difference from nonloaded arm) was used to 
calculate load-induced changes in the second moment. It is also possible that the mutation 
produced poorer localization of new bone to the high-strain periosteal surfaces, which would 
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also affect the change in second moment of area. Other molecules in the Wnt pathway (e.g., 
Sost) are known to control the distribution of new bone formation as a function of 
mechanical strain, so it is possible that βcat might also participate in this effect [40]. Lastly, 
we observed a blunted response to loading on the endocortical surface among induced mice, 
which could have contributed to the lack of geometric adaptation in those samples.
Mechanical stimulation activates Wnt signaling in osteoblasts and osteocytes. Osteoblasts 
subjected to stretching or fluid shear stress exhibit many hallmarks of activated canonical 
Wnt, including translocation of βcat to the nucleus and Wnt target gene (or reporter gene) 
expression [16, 17]. We and others found that loss of Lrp5 either globally [20, 21], or locally 
in Dmp1-expressing cells [41], inhibits load-induced bone formation, which casts little 
doubt that Wnt/Lrp5 is required for mechanotransduction in bone. It is therefore perplexing 
that the putative key downstream node in activated Lrp5 signaling—βcat—in the same cell 
type (Dmp1-expressing) is dispensable for load-induced bone formation. Further evidence 
for a disconnect between Lrp5 and βcat has been reported recently, where load-induced βcat 
reporter expression in vivo can occur independent of Lrp5/6 activation [42].
Recently, Javaheri et al. reported that deletion of a single copy of βcat in osteocytes 
beginning at conception (10kbDmp1-Cre × βcat+/f) abolished the anabolic response to 
mechanical loading in 18–24 wk-old mice [43]. While their loading protocol employed 
similar levels of strain (2500 με vs. our 2800 με) but a longer duration (3 wks vs. our 1 wk), 
their conclusions diverge from ours in some aspects. Several experimental design differences 
between the two studies are noteworthy and might explain the inconsistencies in results. 
First, we used a tamoxifen-inducible Cre model in homozygous floxed mice, whereas their 
experiments were conducted using a stable Cre model in heterozygous floxed mice. At least 
one report indicates that tamoxifen can complicate mechanotransduction studies by 
enhancing load-induced bone formation [44]. We attempted to control for this effect by 
measuring the effect of corn oil or tamoxifen administration to CreERt2− mice (i.e., no 
CreErt2 target for tamoxifen) on the loading response. A significant tamoxifen-associated 
increase in periosteal bone formation rate was detected in the non-loaded ulna, but not in the 
loaded ulna. It is possible, however, that tamoxifen still had some influence on load-induced 
bone formation in the CreERt2+ mice (i.e., interaction with βcat loss) that was not detected 
by our design. Second, we used homozygous βcat flox mouse model rather than a 
heterozygous model. We measured an 80% reduction in βcat expression in tamoxifen-treated 
CreERt2+ mice, compared to oil-treated CreERt2− mice; it is unclear the degree of βcat 
suppression achieved by the 10kbDmp1-Cre × βcat+/f reported in [43] was greater or less than 
the level of suppression we generated. Third, unlike the 10kbDmp1-Cre transgenic, 
the 10kbDmp1-CreERt2 model avoids recombination in skeletal muscle if the transgene is 
induced postnatally. As considerable muscle–bone crosstalk axis has been identified in 
recent years, it is unclear whether βcat deletion from skeletal muscle influences mechanical 
signaling in bone via yet unidentified myokines [45].
This study has several inherent limitations. First, the Cre mouse model we chose to use for 
these experiments precluded the possibility of gene deletion without the confounding effects 
of tamoxifen. We attempted to address this limitation experimentally by including CreERt2− 
controls that were treated with and without tamoxifen. Second, our use of the inducible Cre 
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model, in contrast to the non-inducible Dmp1-Cre model, might have resulted in retention of 
a subpopulation of osteocytes that escaped recombination after tamoxifen induction. This is 
possible because the Dmp1 promoter is more active in early osteocytes and exhibits 
markedly reduced expression in mature osteocytes. Thus, some of the mature osteocytes 
might not have recombined one or both βcat alleles due to downregulated transgene 
promoter activity. If so, the “escaped” osteocytes might be capable of contributing to the 
load-induced bone formation we observed in otherwise recombined tissue. Lastly, the 
inducible Dmp1-CreERt2 model exhibits a measureable amount of “leakiness.” We report 
here (e.g., Fig. 1) and others report elsewhere [32] that this mouse model undergoes 
recombination in a fraction of cells in the absence of tamoxifen. Previous reports using 
tdTomato fluorescent reporter mice indicated that 10–20% of the osteocytes undergo 
recombination prior to chemical induction [32], whereas our expression studies from laser 
captured cortical tissue indicate that the floxed βcat gene exhibited around 40% reduction in 
unprovoked recombination. It is likely that each gene will have different sensitivities to 
unprovoked recombination based on accessibility of the loxP sites and other local nuclear 
matrix properties.
In conclusion, our experiments suggest that osteocyte-selective βcat deletion from the adult 
skeleton leads to a decrease in skeletal mass and density, but not in periosteal load-induced 
bone formation at the ulnar midshaft. However, the preserved effects of mechanical 
stimulation in βcat-deficient mice were not observed on the endocortical surface and did not 
translate into improvements in the second moment of area, a hallmark of mechanical 
adaptation in nonmutant mice. These findings suggest that the role of βcat in 
mechanotransduction might be more complicated than previously thought, and raise the 
possibility that other additional downstream mediators (or effectors) of Wnt/Lrp5 might 
transduce mechanical signals in bone tissue.
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Highlights
• Adult-onset deletion of β-catenin from Dmp1-expressing cells results in 
measurable reduction in bone mass and density over a 4-wk period.
• Mice with induced deletion of β-catenin in Dmp1-expressing cells were 
responsive to mechanical stimulation, though baseline bone formation was 
suppressed
• Geometric adaptation of the midshaft ulna was compromised in loaded β-catenin 
deficient mice.
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Fig. 1. 
(A) Schematic diagram of the experimental design. To induce recombination of the floxed 
βcat alleles in fully adult mice, tamoxifen (Tam) was first injected at 17 wks of age, then 
several times thereafter to ensure recombination. Numbers in parentheses indicate days 
between manipulations. (B) To assess βcat expression in bone and muscle after tamoxifen-
induced Cre translocation, RNA from cortical bone and muscle were collected by laser 
capturing technique from frozen sections. Moving from left to right, the panels show a 
portion of the femur cortex with the laser ROI indicated by the dashed box (left), the section 
midway through the laser capture process (middle), and the section after the defined cortical 
bone region had dropped into the cap (right) for analysis. Original lens magnification is 10X. 
(C) Real time PCR revealed a significant tamoxifen-induced reduction in βcat expression in 
the laser captured fragments in both Cre genotypes (* p < 0.05 compared to CreERt2− with 
Oil group, + p < 0.05 compared to CreERt2− with tamoxifen group, # p < 0.05 compared to 
CreERt2+ with Oil group) and a roughly 50% reduction in βcat expression among CreERt2+ 
mice that were not exposed to tamoxifen. (D) βcat expression in muscle fragments was fairly 
consistent across genotype/treatment (with the exception of tamoxifen-treated CreERt2− 
mice) groups, indicating a lack of Cre nuclear activity in muscle tissue with this model. 
Sample size is n=10/group.
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Fig. 2. 
Bone mineral content (BMC) was measured by DEXA at the end of the experiment (21 wks 
of age) using an ROI that encompassed (A) the whole body, (B) the lumbar spine (L3–L5, 
inclusive), and (C) the hindlimb (all skeletal tissue distal to the acetabulum). Tamoxifen 
reduced BMC in Cre-positive mice but not in Cre negative mice (* p < 0.05 compared to 
CreERt2− with Oil group, + p < 0.05 compared to CreERt2− with tamoxifen group, # p < 
0.05 compared to CreERt2+ with Oil group). (D–F) Bone mineral density (BMD) was also 
obtained from the same DEXA scans, and yielded similar reductions in skeletal properties 
among the βcat–recombined mice. Sample size is n=10/group.
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Fig. 3. 
Mechanical loading generated new bone formation at the ulnar midshaft site in Cre-induced 
and control mice. (A) Periosteal mineralizing surface per bone surface (MS/BS; panel B), 
periosteal mineral apposition rate (MAR; panel C), and periosteal bone formation rate per 
unit bone surface (BFR/BS; panel D) were all significantly increased by mechanical loading, 
compared to the control ulna, within each genotype/treatment group (not indicated by 
symbols in figure; * p < 0.05 compared to CreERt2− with Oil group, + p < 0.05 compared to 
CreERt2− with tamoxifen group, # p < 0.05 compared to CreERt2+ with Oil group). (E–G) 
Relative values (right minus left) were calculated for each dynamic formation parameter to 
adjust loading effects for genotype/treatment changes in the baseline (revealed by the 
nonloaded ulna) parameters. The anabolic effect of mechanical loading was not significantly 
inhibited by βcat deletion in tamoxifen-treated CreERt2+ group compared to the remaining 
three groups. Sample size is n=10/group.
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Fig. 4. 
Cross-sectional moments of inertia were calculated from the loaded ulnar sections to 
quantify changes in ulnar adaptation to mechanical loading. (A) Second moment of area 
along the minor axis (IMIN) was calculated before loading (preloading; indicated by the 
calcein label) and after loading (postloading; indicated by the bone edge). % indicates p < 
0.05 compared to preloading values. (B) The ratio of postloading to preloading second 
moment was significantly lower in the βcat recombined group compared to the remaining 
three groups (* p < 0.05 compared to CreERt2− with Oil group, + p < 0.05 compared to 
CreERt2− with tamoxifen group, # p < 0.05 compared to CreERt2+ with Oil group). (C) 
Representative ulnar images of (a) preloading (grey), (b) postloading (black), and (c) areal 
difference between preloading and postloading (black), showing typical geometric 
adaptation in a control mouse. Sample size for the second moment of area is n=10/group.
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